A phase I trial of AEZS-108 (AN-152) in castration- and taxane-resistant prostate cancer.
Stephen V. Liu
No relevant relationships to disclose
Andrew V Schally
No relevant relationships to disclose
Tanya B. Dorff
No relevant relationships to disclose
Denice D. Tsao-Wei
No relevant relationships to disclose
Susan G. Groshen
No relevant relationships to disclose
Shigang Xiong
No relevant relationships to disclose
Debra Hawes
No relevant relationships to disclose
David I. Quinn
No relevant relationships to disclose
Yu-Chong Tai
No relevant relationships to disclose
Norman L. Block
Stock Ownership - Aeterna Zentaris
Juergen Engel
Employment or Leadership Position - Aeterna Zentaris
Stock Ownership - Aeterna Zentaris
Other Remuneration - Aeterna Zentaris
Jacek K. Pinski
No relevant relationships to disclose